Duration and level of transgene expression after gene electrotransfer to skin in mice

被引:30
作者
Gothelf, A. [1 ]
Eriksen, J. [1 ]
Hojman, P. [1 ,2 ]
Gehl, J. [1 ]
机构
[1] Copenhagen Univ Hosp, Dept Oncol, Ctr Expt Drug & Gene Electrotransfer, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark
关键词
electroporation; gene electrotransfer; Katushka; erythropoietin; vaccination; IN-VIVO ELECTROPORATION; DNA VACCINE DELIVERY; SKELETAL-MUSCLE; FLUORESCENT PROTEIN; IMMUNE-RESPONSES; ERYTHROPOIETIN; ENHANCEMENT; EFFICIENCY; PULSE; OPTIMIZATION;
D O I
10.1038/gt.2010.35
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In development of novel vaccines, attention is drawn to DNA vaccinations. They are heat stable and can be easily produced. Gene electrotransfer is a simple and nonviral means of transferring DNA to cells and tissues and is attracting increasing interest. One very interesting perspective with gene electrotransfer is that choice of tissue can determine the duration of transgene expression. With gene electrotransfer to muscle, long-term expression, that is beyond 1 year, can be obtained, whereas gene electrotransfer to skin gives short-term expression, which is desirable in, for example, DNA vaccinations. Level and duration of transgene expression after gene electrotransfer to skin is essential and here we present data from two independent quantitative studies. Using in vivo bioimaging of a far-red fluorescent molecule, Katushka, allowing for continuous monitoring of local gene expression, compared with measurements of a systemic transgene, that is, serum erythropoietin (EPO) after gene electrotransfer with EPO to skin, we found a significant increase in transgene expression (P < 0.01) with a peak 9 days (Katushka) and 14 days (EPO) after transfection. Duration of expression could be 3-4 weeks, which is a suitable time frame for vaccinations and is applicable, for example, in gene therapy for wound healing or treatment of cancer. Gene Therapy (2010) 17, 839-845; doi:10.1038/gt.2010.35; published online 8 April 2010
引用
收藏
页码:839 / 845
页数:7
相关论文
共 43 条
[1]   Gene transfer into muscle by electroporation in vivo [J].
Aihara, H ;
Miyazaki, J .
NATURE BIOTECHNOLOGY, 1998, 16 (09) :867-870
[2]   Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin [J].
Babiuk, S ;
Baca-Estrada, ME ;
Foldvari, M ;
Baizer, L ;
Stout, R ;
Storms, M ;
Rabussay, D ;
Widera, G ;
Babiuk, L .
MOLECULAR THERAPY, 2003, 8 (06) :992-998
[3]   High-level gene transfer to the cornea using electroporation [J].
Blair-Parks, K ;
Weston, BC ;
Dean, DA .
JOURNAL OF GENE MEDICINE, 2002, 4 (01) :92-100
[4]   Pharmacodynamics of recombinant human erythropoietin in murine bone marrow [J].
Bugelski, Peter J. ;
Nesspor, Thomas ;
Volk, Amy ;
O'Brien, Joanne ;
Makropoulos, Dorie ;
Shamberger, Kim ;
Fisher, Paul W. ;
James, Ian ;
Graden, Danielle ;
Capocasale, Renold J. .
PHARMACEUTICAL RESEARCH, 2008, 25 (02) :369-378
[5]   Electroporation enhances transfection efficiency in murine cutaneous wounds [J].
Byrnes, CK ;
Malone, RW ;
Akhter, N ;
Nass, PH ;
Wetterwald, A ;
Cecchini, MG ;
Duncan, MD ;
Harmon, JW .
WOUND REPAIR AND REGENERATION, 2004, 12 (04) :397-403
[6]   Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector [J].
Cemazar, M ;
Sersa, G ;
Wilson, J ;
Tozer, GM ;
Hart, SL ;
Grosel, A ;
Dachs, GU .
CANCER GENE THERAPY, 2002, 9 (04) :399-406
[7]   Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor [J].
Daud, Adil I. ;
Mirza, Noweeda ;
Lenox, Brianna ;
Andrews, Stephanie ;
Urbas, Patricia ;
Gao, Gui X. ;
Lee, Ji-Hyun ;
Sondak, Vernon K. ;
Riker, Adam I. ;
DeConti, Ronald C. ;
Gabrilovich, Dmitry .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3235-3241
[8]   Electroporation as a method for high-level nonviral gene transfer to the lung [J].
Dean, DA ;
Machado-Aranda, D ;
Blair-Parks, K ;
Yeldandi, AV ;
Young, JL .
GENE THERAPY, 2003, 10 (18) :1608-1615
[9]   Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation [J].
Dobano, Carlota ;
Widera, Georg ;
Rabussa, Dietmar ;
Doolan, Denise L. .
VACCINE, 2007, 25 (36) :6635-6645
[10]   Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization [J].
Drabick, JJ ;
Glasspool-Malone, J ;
Somiari, S ;
King, A ;
Malone, RW .
MOLECULAR THERAPY, 2001, 3 (02) :249-255